Skip to main content

Peer Review reports

From: Deciphering the mechanism of Indirubin and its derivatives in the inhibition of Imatinib resistance using a “drug target prediction-gene microarray analysis-protein network construction” strategy

Original Submission
23 Oct 2018 Submitted Original manuscript
19 Dec 2018 Reviewed Reviewer Report - Randolph Arroo
27 Dec 2018 Reviewed Reviewer Report - Mokrish Ajat
28 Dec 2018 Reviewed Reviewer Report - Cornelia Braicu
8 Jan 2019 Author responded Author comments - Huayao Li
Resubmission - Version 2
8 Jan 2019 Submitted Manuscript version 2
21 Jan 2019 Reviewed Reviewer Report - Cornelia Braicu
28 Jan 2019 Reviewed Reviewer Report - Randolph Arroo
30 Jan 2019 Author responded Author comments - Huayao Li
Resubmission - Version 3
30 Jan 2019 Submitted Manuscript version 3
6 Feb 2019 Reviewed Reviewer Report - Cornelia Braicu
17 Feb 2019 Reviewed Reviewer Report - Randolph Arroo
18 Feb 2019 Author responded Author comments - Huayao Li
Resubmission - Version 4
18 Feb 2019 Submitted Manuscript version 4
25 Feb 2019 Reviewed Reviewer Report - Randolph Arroo
1 Mar 2019 Reviewed Reviewer Report - Cornelia Braicu
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
4 Mar 2019 Editorially accepted
25 Mar 2019 Article published 10.1186/s12906-019-2471-2

You can find further information about peer review here.

Back to article page